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Subunit 5 of Saccharomyces cerevisiae cytochrome c oxidase
(CcO) is essential for assembly and has two isoforms, 5A and
5B. 5A is expressed under normoxic conditions, whereas 5B
is expressed at very low oxygen tensions. As a consequence,
COX5A-deleted strains (cox5A) have no or only low levels
of CcO under normoxic conditions rendering them respiratory
deficient. Previous studies have reported that respiratory growth
could be restored by combining cox5A with mutations of ROX1
that encodes a repressor of COX5B expression. In these mutants,
5B isoenzyme expression level was 30–50% of wild-type (5A
isoenzyme) and exhibited a maximum catalytic activity up to 3-
fold faster than that of 5A isoenzyme. To investigate the origin
of this effect, we constructed a mutant strain in which COX5B
replaced COX5A downstream of the COX5A promoter. This
strain expressed wild-type levels of the 5B isoenzyme, without
the complication of additional effects caused by mutation of
ROX1. When produced this way, the isoenzymes displayed no
significant differences in their maximum catalytic activities or in
their affinities for oxygen or cytochrome c. Hence the elevated
activity of the 5B isoenzyme in the rox1 mutant is not caused
simply by exchange of isoforms and must arise from an additional
effect that remains to be resolved.
Key words: complex IV, cytochrome c oxidase, Michaelis–Men-
ten constant, oxygen affinity, subunit 5 isoform, turnover number.
INTRODUCTION
Mitochondrial CcO (cytochrome c oxidase) is the terminal
enzyme of the respiratory chain that catalyses electron transfer
from cyt c (cytochrome c) to oxygen. The reaction is coupled
to the translocation of protons across the mitochondrial inner
membrane, forming a protonmotive force used to drive ATP
synthesis and giving an overall reaction of: 4 cyt c2 + + 8
H+ mitochondrial matrix + O2→4 cyt c3 + + 4 H+ intermembrane space + 2
H2O. Saccharomyces cerevisiae CcO is composed of at least 11
subunits. Subunits I, II and III are encoded by the mitochondrial
genome and constitute the essential catalytic core where the metal
centres CuA (subunit II), haem a, haem a3 and CuB (subunit I),
the hydrophilic pathways for proton transfer (subunit I) and the
oxygen entrance pathway (subunit III) are located. These subunits
are conserved across eukaryotic and prokaryotic homologues.
The remaining eight supernumerary subunits, which do not
have bacterial homologues, are encoded by the nuclear genome.
They are homologous with eight of the ten supernumerary
subunits of human/bovine CcO [1–3]. Some of these mammalian
supernumerary subunits are involved in assembly, dimerization
or stability. Others may provide means of regulation by allosteric
control, for example via ligand-binding [4–6] or phosphorylation
sites [7,8].
Five of the mammalian supernumerary subunits display
isoforms that are differentially expressed depending on the tissue
type or stage of development [6,9,10]. Subunit IV, the largest of
the supernumerary subunits (∼17 kDa), is of particular interest. It
has a single membrane spanning α-helix that is closely associated
with helices 11 and 12 of core subunit I. A hydrophilic C-
terminal domain projects into the intermembrane space close to
the cyt c-binding site on subunit II, and a hydrophilic N-terminal
domain projects into the matrix [11]. ATP/ADP-binding sites are
predicted on both matrix [4] and cytosolic [5] domains that can
allosterically inhibit CcO activity by exchanging bound ADP
for ATP at high ATP/ADP ratios, hence providing a negative-
feedback loop mechanism of respiratory control [12–14]. It was
reported that cAMP-dependent phosphorylation of Ser58, located
in the matrix domain of subunit IV, modulates the respiratory
activity by controlling ATP allosteric inhibition [15]. This serine
residue is conserved in mammalian CcOs but not in other species.
Furthermore, subunit IV has two isoforms: IV-2 is predominantly
expressed in lung, neurons and fetal muscle, whereas IV-1 is
expressed across all tissue types [16,17]. IV-2 expression has been
shown to be induced by hypoxic conditions under the control of
RBPJ (recombination signal-binding protein for immunoglobulin
κJ region), CXXC5 and CHCHD2 (coiled-coil-helix-coiled-coil-
helix domain containing 2) transcription factors [18] or by toxins
[19]. The IV-2 isoenzyme from lung has been reported to have a
faster turnover activity than the IV-1 isoenzyme from liver [12].
In addition, IV-2 expression abolishes the allosteric inhibition by
ATP [6,16].
Subunit 5 of yeast CcO is homologous with mammalian subunit
IV [1] and also displays two isoforms (5A and 5B) [20,21] that
are encoded by single-copy genes: COX5A on chromosome 14
and COX5B on chromosome 9. They share 67% nucleotide
(66% amino acid) identity and are thought to have arisen from
gene duplication followed by sequence divergence 130 million
years ago [21]. One or other polypeptide is essential for CcO
assembly. Structurally, they are superimposable on the crystal
structure of subunit IV of bovine CcO [3,22]. However, matching
of specific isoforms to those of mammalian subunit IV (5A with
Abbreviations: CcO, cytochrome c oxidase; cyt c, cytochrome c; mitos, mitochondrial membranes; DDM, n-dodecyl β-D-maltoside; TMPD, N,N,N′,N′-
tetramethyl-p-phenylenediamine; CCCP, carbonyl cyanide m-chlorophenylhydrazone.
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Table 1 Saccharomyces cerevisiae strains used.
Strain Genotype Description and respiratory growth phenotype
WTCOX5A COX5A Expression of COX5A under normal aerobic growth conditions. Respiratory growth
competent
COX5A cox5a::URA3 Deletion of COX5A . Respiratory growth deficient
COX5ApCOX5A cox5a::URA3, pCOX5A COX5A cloned on a centromeric plasmid under the control of its own promoter.
Deletion of genomic COX5A . Respiratory growth competent
COX5B cox5a::COX5B Replacement of COX5A by COX5B downstream of the COX5A promoter on the
nuclear genome. Expression of COX5B under normal aerobic growth conditions.
Respiratory growth competent
pCOX5B cox5a::URA3, pcox5a::COX5B COX5B cloned downstream of COX5A promoter on a centromeric plasmid. Deletion
of genomic COX5A . Respiratory growth competent
ROX1COX5A rox1::kanMX4, cox5a::URA3 Up-regulation of COX5B through deletion of its transcription repressor ROX1 in
COX5A -deleted background. Weak respiratory growth
ROX1COX5ApCOX5A rox1::kanMX4, cox5a::URA3, pCOX5A COX5A with its own promoter on a centromeric plasmid. Deletion of ROX1, the
transcription repressor of COX5B. Respiratory growth competent
ROX1COX5ApCOX5B rox1::kanMX4, cox5a::URA3, pcox5a::COX5B COX5B cloned downstream of the COX5A promoter on a centromeric plasmid.
Deletion of ROX1, the transcription repressor of COX5B, in COX5A -deleted
background. Respiratory growth competent
IV-1/IV-2 and 5B with IV-2/IV-1) is not possible based on the
modest sequence identity of ∼20% for each combination [3].
As with the mammalian subunit IV isoforms, the expression
pattern of subunits 5A and 5B is controlled by oxygen (and haem)
concentration [23,24]. Subunit 5A is expressed above 1 μM O2
and subunit 5B under low (<1 μM O2) oxygen concentrations
[25]. Oxygen stimulates haem synthesis that then binds to and
activates the transcription inducer Hap2/3/4/5 complex of COX5A;
haem also activates Hap1 that induces the expression of Rox1,
a repressor of COX5B expression. Under low oxygen, haem
levels fall and Hap1 and Hap2/3/4/5 are no longer activated.
This prevents COX5A transcription and loss of Rox1 transcription
allows derepression of a set of hypoxic genes including COX5B
[26,27].
Since subunit 5A or 5B is required for CcO assembly, CcO
is not assembled or is at very low levels in COX5A-deleted
strains at normal oxygen levels. If additionally the rox1 gene is
mutated, the COX5B gene is expressed at normal oxygen levels,
resulting in an assembled 5B isoenzyme [24]. However, the CcO
level was lower by a factor of 2–3 compared with the control
COX5A-expressing strain. Intriguingly, it was observed that the
5B isoenzyme had a turnover number that was up to 3-fold faster
than that of the 5A isoenzyme [28–30]. This was linked to an
increased electron transfer rate from haem a to a3 in vivo. The
subunit 5 isoforms were proposed to mediate their effects by
allosterically altering the protein environment around haems a and
a3 [28,29]. Infrared studies on CO bound CcO also indicated that
the 5A isoform had two interchangeable conformers (CI and CII)
whereas the 5B isoform had only the CII conformer. This led to the
hypothesis that the CII conformer was capable of faster turnover
activity [28].
In order to investigate the properties of the 5A and 5B
isoenzymes more directly, we constructed a mutant strain
expressing only subunit 5B by replacing the COX5A open reading
frame with COX5B so that it was under the control of the
COX5A promoter. This mutant expressed the 5B isoenzyme at
normal levels under aerobic growth conditions, and allowed
comparisons of the catalytic properties of the isoenzymes without
the complication of low expression levels or of other possible
changes caused by mutations in the transcription factor Rox1. As a
further control, a mutant equivalent to that previously reported was
constructed in which COX5B expression was achieved through
deletion of ROX1 in a COX5A-deleted strain and thereby allowed
us to compare 5A and 5B isoenzyme kinetics in a controlled
manner.
MATERIALS AND METHODS
Chemicals were purchased from Sigma–Aldrich. Yeast iso-1 cyt
c and iso-2 cyt c were a gift from B. Guiard (CGM, CNRS, Gif-
sur-Yvette, France).
Yeast strains
All strains (Table 1) were constructed from a modified S.
cerevisiae strain W303-1B (αade2 HIS3 leu2 trp1 ura3) that
expressed wild-type CcO with a His6 tag sequence attached to
Cox13 [31]. Deletion and gene replacement were performed via
homologous recombination of PCR products. The PCR products
and gene replacements were confirmed by DNA sequencing.
The plasmid pRS415-COX5A containing COX5A gene under the
control of its promoter and terminator was a gift from D. Winge
(University of Utah, Salt Lake City, UT, U.S.A.).
Growth conditions and mitochondrial membrane preparation
Respiratory growth competence was checked on YPG medium
(1% yeast extract, 2% peptone, 2% glycerol and 2% agar). All
strains were grown in YPGal (1% yeast extract, 2% peptone
and 2% galactose) and their mitos (mitochondrial membranes)
were prepared by published protocols [31] and stored in 50 mM
potassium phosphate and 2 mM EDTA, pH 7.4. Concentrations
of CcO were measured from sodium dithionite reduced minus
oxidized difference spectra at 605–621 nm with an absorption
coefficient, ε, of 26 mM− 1·cm− 1 or at 445–465 nm with a ε of
204 mM− 1·cm− 1 (based on values for bovine CcO [32]). Protein
contents were determined using the Bradford assay [33].
Preparation of cyt c
Horse heart, yeast iso-1 cyt c (isoform-1) and iso-2 cyt c (isoform-
2) stock solutions were prepared by washing with 20× volume
c© 2014 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted
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of the reaction buffer (10 mM potassium phosphate, pH 6.6, and
50 mM KCl) using a 10 kDa Vivaspin centrifugal concentrator at
4 ◦C and 10000 g. The cyt c concentrations were measured from
visible absorption spectra of sodium dithionite reduced samples,
using an ε of 27.7 mM− 1·cm− 1 at 550 nm [34].
Determination of oxygen affinity
The Km of CcO for oxygen was measured using the myoglobin
method [35]. Oxygen consumption rates at low oxygen
concentrations were monitored by following the conversion of
oxymyoglobin into myoglobin at 582–564 nm using a Shimadzu
dual-wavelength spectrophotometer. Oxygenated myoglobin was
prepared by reduction with sodium ascorbate, followed by
separation into aerobic 10 mM potassium phosphate (pH 6.6)
and 50 mM KCl with a Sephadex G-25 column (15 cm × 1 cm).
The total myoglobin concentration was measured from a visible
absorption spectrum of a dithionite reduced sample, using an ε
of 12.92 mM− 1·cm− 1 at 555 nm [36] and samples were typically
85% in the oxyferrous form and 15% in the ferric form. The
reaction was carried out in a stoppered cuvette with stirring
at 25 ◦C. The cuvette was filled with a total volume of 3.8 ml
of 10 mM potassium phosphate (pH 6.6), 50 mM KCl, 0.05%
DDM (n-dodecyl β-D-maltoside; Melford Laboratories), 2 mM
sodium ascorbate, 40 μM TMPD (N,N,N ′,N ′-tetramethyl-p-
phenylenediamine, a redox mediator), 30 μM total myoglobin and
mitos to give 1–3 nM CcO. After the baseline had stabilized, the
reaction was initiated with 50 μM horse heart cyt c. The reaction
was complete in 10–15 min. The ratio of oxyferrous/ferrous
myoglobin was used to determine both free oxygen concentrations
and rates of oxygen consumption, using an oxygen dissociation
constant of 1.34 μM [37]. These values were used to determine
the Km of CcO for oxygen by non-linear fitting of data to the
Michaelis–Menten equation using the curve-fitting toolbox in
MatlabTM.
Determination of turnover numbers and kinetic parameters for cyt c
Steady-state oxygen consumption rates were measured in a stirred
reaction vessel of a Clark-type O2 electrode at 25 ◦C. Assays with
whole cells were carried out using 12.5 mg/ml cells giving 10–
25 nM CcO in 50 mM potassium phosphate (pH 7.2), 440 mM
sucrose, 10 mM lactate, 1.8 μM CCCP (carbonyl cyanide m-
chlorophenylhydrazone) and 1 μM valinomycin [38]. Assays
with mitos were carried out using membranes containing 2–10 nM
CcO in 10 mM potassium phosphate, pH 6.6, 50 mM KCl, 0.05%
DDM, 2 mM sodium ascorbate and 40 μM TMPD. The assay
conditions for wild-type yeast CcO oxidizing horse heart cyt c
were optimized in WTCOX5A mitos for pH (range 5.8–7.4),
ionic strength (using 0–130 mM KCl), DDM concentration (0–
0.2%) and horse heart cyt c concentration. The optimum assay
conditions were pH 6.6, 0.05% DDM and 50 mM KCl. Under
these conditions 50 μM horse heart cyt c produced rates that were
close to Vmax. These conditions were assumed to be also optimal
for yeast iso-1 and iso-2 cyts c. Initially, a baseline was measured
in the absence of cyt c and then the reaction was initiated by
addition of 50 μM cyt c. Turnover numbers and rates are expressed
in terms of the number of electrons transferred from cyt c per s per
CcO (e·s− 1). Rates at each cyt c concentration were averaged from
two to four repeats. Vmax and Km values were determined using
non-linear fitting of the Michaelis–Menten equation for single
phase kinetics and with the sum of two Michaelis–Menten terms
for plots that displayed biphasic kinetics using the curve-fitting
toolbox in MatlabTM.
RESULTS
Cell growth and CcO expression levels
All of the mutant strains constructed and analysed in the present
study are listed in Table 1. The COX5B gene at its genomic locus
was not deleted in these mutants since its expression relies on
hypoxic conditions and hence is not expressed under the aerobic
growth conditions used in the present study. Thus the COX5A-
deleted strain could not grow on respiratory medium (YPG).
In order to compare the catalytic activity of 5A and 5B isoen-
zymes in the COX5A-deleted strain, we replaced COX5A by
COX5B both in the COX5A genomic locus and on a centromeric
plasmid. In both cases, COX5B expression was under the control
of the COX5A promoter, the 5B isoenzyme was expressed at
normal levels under aerobic growth conditions, and the cells
were respiratory growth competent. When the deletion of COX5A
was combined with deletion of ROX1, encoding a transcription
repressor of COX5B, the resulting mutant was also respiratory
growth competent, as previously reported, although the growth in
respiratory medium was slower than the wild-type control.
Strains were grown to late exponential phase (logD = 0.9–1)
in YPGal medium for 14–16 h at 28 ◦C. All displayed a wild-
type doubling time of 2.7–3.0 h. This yielded 11 g of wet mass of
cells per litre of culture for all strains except ROX1COX5A,
which yielded ∼6 g. The difference in biomass was most
probably due to the difference in respiration/fermentation ratio
of ROX1COX5A when grown to late exponential phase in
galactose medium. The doubling times were measured during
early exponential phase where the strains might use more
fermentation than respiration, thus no difference in doubling times
could be observed between strains.
Reduced minus oxidized visible absorbance difference spectra
of whole cells confirmed the presence of CcO at approximately
2 nmol of CcO per g of wet weight cells in COX5B, pCOX5B,
ROX1COX5ApCOX5A and ROX1COX5ApCOX5B,
consistent with the level in the WTCOX5A strain. The CcO
level in ROX1COX5A cells was significantly less than
1 nmol·g− 1, although difficult to quantify accurately in whole cell
spectra.
Redox spectra of mitos allowed accurate quantification of
CcO in all strains from either the visible band at 605–
621 nm or the Soret band at 445–465 nm [32]. For comparison,
Figure 1 includes a spectrum of COX5A mitos which have
no assembled CcO. Mitos from WTCOX5A, COX5B, pCOX5B,
ROX1COX5ApCOX5A and ROX1COX5ApCOX5B
have approximately equivalent levels of CcO (0.23–0.31 nmol
per mg of mitochondrial protein; nmol of CcO·mg− 1), whereas
mitos from ROX1COX5A contained 5–6-fold less CcO
(0.05 +− 0.01 nmol·mg− 1). However, the level of bc1 complex
remained fairly constant in mitos from all strains, including
those derived from ROX1COX5A, at 0.76–1.2 nmol of bc1
complex·mg− 1 (as measured from the visible band at 562–575 nm
using an ε of 28 mM− 1·cm− 1) (Figure 1) [32]. Hence the ratio of
CcO to bc1 complex in ROX1COX5A mitos was also ∼6-fold
less (∼0.04:1) than the ratio (0.25:1) in mitos derived from strains
WTCOX5A, COX5B, pCOX5B, ROX1COX5ApCOX5A and
ROX1COX5ApCOX5B.
Turnover numbers in whole cells
The steady-state turnover numbers of CcO in whole cells under
uncoupled conditions are shown in Figure 2(A). Strains that
expressed the 5B isoenzyme under the control of the COX5A
promoter from either the nuclear genome (strain COX5B) or
c© 2014 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted
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Figure 1 Dithionite reduced minus oxidized visible difference spectra of
WTCOX5A (dashed), ROX1COX5A (continuous) and COX5A (dotted)
mitos preparations
Mitos were diluted in 50 mM potassium phosphate (pH 7.4) and 2 mM EDTA. 605 nm band is
of CcO and 562 nm band is of the bc1 complex. Spectra illustrate a ∼6-fold smaller CcO/bc1
ratio in ROX1COX5A. COX5A lacks CcO. The spectra in the 500–700 nm range have
been expanded 8-fold for clarity.
from a plasmid (pCOX5B and ROX1COX5ApCOX5B) had
turnover numbers in the same range as the 5A isoenzyme (∼330
e·s− 1) that had been expressed either in wild-type cells or from
a plasmid (ROX1COX5ApCOX5A). However, when the 5B
isoenzyme was expressed under its own promoter after deletion
of ROX1 in the ROX1COX5A strain, it displayed a turnover
number at least 2.6-fold higher, confirming the prior literature
reports [29]. The activity of CcO of ROX1COX5A expressed
as e·s− 1·g− 1 of wet weight of whole cells was also greater (∼1.4-
fold).
Turnover numbers in mitos preparations
The uncoupled turnover numbers of CcO in whole cells will most
probably be limited by additional factors, and so turnover numbers
in isolated mitos were also compared using conditions that had
been optimized for oxidation of horse heart cyt c (Figure 2B). In
addition, turnover numbers were determined using yeast iso-1 cyt
c and iso-2 cyt c under the same conditions (see the Discussion
section). For all strains under these conditions, activities were
fastest with horse heart cyt c, followed by yeast iso-2 cyt c. In
agreement with whole cell turnover values, CcO in mitos isolated
from the ROX1COX5A strain had an approximately 2-fold
greater turnover number compared with that in all other strains,
irrespective of the cyt c substrate used (Figure 2B). However, the
CcO activity per mg of mitochondrial protein was ∼3-fold less
than that in the other strains (140 e·s− 1·mg− 1 compared with 380
e·s− 1·mg− 1) because of the lower level of CcO per mg of protein.
Determination of Km for oxygen
Rates of oxygen consumption in the concentration range of the
Km for oxygen of CcO were determined by the oxymyoglobin
method [35]. Km and Vmax values for WTCOX5A, COX5B
and ROX1COX5A mitos are summarized in Table 2 and
Michaelis–Menten plots are shown in the Supplementary Figure
S1. All strains exhibited approximately the same Km, although the
Vmax of ROX1COX5A was at least 1.5-fold greater compared
with that of WTCOX5A and COX5B.
Figure 2 Turnover numbers of yeast CcO strains in (A) whole cells and (B)
mitos preparations using horse heart cyt c (grey), yeast iso-1 cyt c (hatched)
and yeast iso-2 cyt c (white) as substrate
(A) In whole cells turnover numbers were measured using an oxygen electrode with 12.5 mg/ml
cells containing 10–25 nM CcO in 440 mM sucrose, 50 mM potassium phosphate (pH 7.2),
10 mM lactate, 1.8 μM CCCP and 1 μM valinomycin at 25◦C. (B) In mitos preparations
turnover numbers were measured using 10–50 μl of mitos containing 2–10 nM CcO in 10 mM
potassium phosphate (pH 6.6), 50 mM KCl, 0.05 % DDM, 40 μM TMPD and 2 mM sodium
ascorbate at 25◦C and 1 ml final volumes. Once the baseline had stabilized 50 μM cyt c was
added to initiate the reaction. Results are means +− S.D. for two to four repeats.
Km and Vmax for cyt c
Michaelis–Menten plots for WTCOX5A, COX5B and
ROX1COX5A mitos are shown in Figure 3 and the derived
Vmax and Km values for horse heart, yeast iso-1 and iso-2 cyts c
are summarized in Table 3. Under these assay conditions, the data
displayed monophasic kinetics for horse heart cyt c but biphasic
kinetics for yeast iso-1 and iso-2 cyt c. Eadie–Hofstee plots of the
data and the fits are shown in Supplementary Figure S2 as these
illustrate the mono- or bi-phasic kinetic behaviour more clearly.
WTCOX5A and COX5B displayed the same Vmax and Km values
irrespective of the cyt c source, whereas the ROX1COX5A
strain again had a Vmax 1.5–2-fold greater, but with a similar Km.
DISCUSSION
Incorporation of subunit 5 (A or B) is essential for the stable
expression of optically detectable functional CcO [20,39] and
c© 2014 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted
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Figure 3 Michaelis–Menten plots of WTCOX5A (), COX5B () and ROX1COX5A (×) mitos using horse heart cyt c (A), yeast iso-1 cyt c (B) and yeast
iso-2 cyt c (C)
Reaction conditions were the same as in Figure 2(B), but the rate was measured at multiple cyt c concentrations (1.25–350 μM). V max and K m values (see Table 3) were determined using non-linear
fitting of the Michaelis–Menten equation for data displaying single phase kinetics (A) and two Michaelis–Menten terms for those with biphasic kinetics (B and C).
Table 2 Comparison of oxygen affinities and Vmax of WTCOX5A, COX5B and
ROX1COX5A mitos
The K m and V max values were determined using non-linear fitting of the Michaelis–Menten
equation to plots shown in Supplementary Figure S1. Error values are 95 % confidence intervals
given by the t -distribution.
Substrate Strain (mitos) V max (μM O2/s per μM CcO) K m (μM)
Oxygen WTCOX5A 184 +− 12 0.85 +− 0.1
COX5B 154 +− 9 0.74 +− 0.1
ROX1COX5A 302 +− 21 0.86 +− 0.2
hence the level of detectable CcO is a direct measure of the level
of functionally incorporated subunit 5. It has also been shown
that the COX5B isoform is not expressed under aerobic growth
conditions [24]. Hence, for those strains used to generate the 5A
isoenzyme of CcO, the optically detected CcO will have only
subunit 5A since they were grown aerobically. For those strains
used to generate the 5B isoenzyme, 5A isoenzyme was absent
since the COX5A gene was replaced entirely by COX5B.
COX5A deletion (cox5A) results in a lack of respiratory
competence [24] and absence of CcO (Figure 1). Respiration-
competent mutants of such a cox5A strain had mutations in
ROX1, a repressor of COX5B, that resulted in the enhanced
expression of COX5B [24]. The 5B isoenzyme was up to 3-
fold more catalytically active than the 5A isoenzyme. The results
of the present study with the ROX1COX5A mutant confirm
this observation. A 2-fold faster 5B isoenzyme activity was also
observed in a COX5A-deleted strain with wild-type ROX1 and
with COX5B cloned on a high copy plasmid [30]. However, in
all of these strains, the level of CcO was significantly diminished
in comparison with wild-type levels: 34% of the control in the
strain with both cox5A and rox1 mutations [29]; and less than
50% in the cox5A strain with higher copy number of COX5B
[30]. It was also substantially decreased in the ROX1COX5A
strain described in the present study.
In order to circumvent such complications, we generated
COX5A-deleted mutants in which the COX5B was placed
downstream of the COX5A promoter on the genomic locus,
similarly to the chimaeric constructs described in [39]. In addition,
COX5A-deleted strains with or without ROX1 deletion were
transformed with a centromeric plasmid to express 5A or 5B
isoforms under the control of the COX5A promoter. This enabled
expression of 5A or 5B isoforms at wild-type levels and at
normal oxygen concentrations and with the same status (present
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Table 3 Comparison of Vmax and Km of WTCOX5A, COX5B and
ROX1COX5A mitos for horse heart cyt c, yeast iso-1 cyt c and iso-2
cyt c
The V max and K m values were determined using non-linear fitting of a single Michaelis–Menten
equation for assays with horse heart cyt c and with two Michaelis–Menten terms for assays with
yeast iso-1 and iso-2 cyt c that displayed biphasic kinetics (Figure 3). Error values are 95 %
confidence intervals given by the t -distribution.
Substrate Strain (mitos) Low-affinity phase
V max (e·s− 1) K m (μM)
Horse heart cyt c WTCOX5A 1803 +− 50 13.9 +− 2
COX5B 1831 +− 80 14.5 +− 2
ROX1COX5A 2764 +− 140 10.8 +− 2
Yeast iso-1 cyt c WTCOX5A 1231 +− 100 29.8 +− 11
COX5B 951 +− 120 39.5 +− 19
ROX1COX5A 2060 +− 200 41.2 +− 18
Yeast iso-2 cyt c WTCOX5A 1448 +− 140 23.9 +− 7
COX5B 1765 +− 180 59.5 +− 7
ROX1COX5A 3238 +− 660 47.8 +− 24
or deleted) of ROX1. In these constructs, 5A and 5B isoenzymes
failed to show any difference in their Km values for oxygen
(∼0.8 +− 0.1 μM), that are in a similar range to those (1 μM[40] and 0.95 μM [41]) reported for bovine CcO. This latter
comparison was carried out since their expression is differentially
regulated by oxygen concentration. Similarly, the Vmax and Km
values for cyt c from horse heart showed no differences between
WTCOX5A and COX5B but were ∼1.5-2-fold greater in Vmax in
the 5B isoenzymes of CcO expressed in the ROX1COX5A
strain. The Vmax and Km values of WTCOX5A with horse heart
cyt c reported in the present study are in a range consistent with
Geier et al. [42] (Vmax 1773 e·s− 1, Km 15.3 μM).
Equivalent Vmax and Km measurements were made using S.
cerevisiae cyt c (Figure 2B and Table 3) since two isoforms are
differentially expressed depending on the oxygen levels. Iso-1
cyt c is predominantly expressed under normal oxygen levels
and iso-2 cyt c under hypoxic conditions [25,26]. Once again no
significant difference in Vmax was observed between WTCOX5A
and COX5B (Figure 2B and Table 3). The Vmax and Km values with
yeast iso-1 and iso-2 cyt c are much greater than those reported
(Vmax < 40 s− 1; Km < 10 μM; [28]). Apart from the overall assay
conditions and possibly the method used to prepare mitos, these
differences in Vmax and Km could be due to the higher and more
physiologically relevant (0.5 mM cyt c [43]) cyt c concentration
range used in the present study (∼300–1.25 μM) compared with
the range (20–0.05 μM) used by Allen et al. [28]. WTCOX5A,
COX5B and ROX1COX5A strains shared the same Km values
for cyt c (Table 3), as was also observed by Allen et al. [28].
Noticeably, for all strains, the Vmax values were in the order:
horse heart > iso-2 > iso-1 cyt c (Figure 2B and Table 3). This
finding conflicts with the previous report of faster activity with iso-
1 cyt c compared with iso-2 cyt c [28]. However, this is probably
accounted for by the different conditions of measurement, which
in the present study were optimized in pH and ionic strength
for horse heart cyt c. More significantly, it was reported that the
isoenzymes showed different relative rates with the cyt c isoforms,
with selectivity ‘dampened’ from 4-fold to 1.6-fold when the
physiologically relevant aerobic (CcO isoenzyme 5A/iso-1 cyt c)
and hypoxic (CcO isoenzyme 5B/iso-2 cyt c) isoforms were paired
together [28]. However, no preferences for specific cyt c isoforms
were evident in the 5A and 5B isoenzymes in the present study
and, if anything, the opposite effect was observed when comparing
WTCOX5A/iso-1 cyt c and ROX1COX5A/iso-2 cyt c pairs
(Figure 2B and Table 3).
Biphasic kinetics (Figure 3 and Supplementary Figure S2)
were observed for yeast cyt c, consistent with previous data
[28], whereas horse heart cyt c exhibits single phase kinetics
consistent with the findings in [42]. The phenomenon has been
well-documented for many types of CcO and with different
types of cyts c (including yeast CcO) [44,45]. Several models
have been proposed to explain the biphasic behaviour. One model
is that there are two catalytic sites on CcO that can bind cyt c
with different affinities [44]. A second proposal is that there is
a non-catalytic binding site for cyt c, either very close to the
catalytic site and so allowing direct interaction with substrate
[46], or at a distance and acting allosterically [47]. The transition
of high-affinity to low-affinity phase, was suggested to arise from
an increase in the dissociation rate constant of ferricyt c (the rate-
limiting step) when the regulatory site was bound by a second
cyt c. Most recently, it was proposed that oxidized cyt c also acts
as a competitive inhibitor of CcO, which is in addition to the
effects of binding of cyt c to a second regulatory site [48]. For
the purpose of the present study, a comparison of WTCOX5A,
COX5B and ROX1COX5A isoenzymes has been made with
the high-velocity/low-affinity phase data since it is the phase
that may predominate under physiological conditions since cyt
c concentration in the intermembrane space is at 0.5 mM [43] and
it is observed for horse heart, yeast iso-1 and iso-2 cyt c (Table 3).
To summarize, yeast strains that express the 5A or 5B
isoenzymes to the same levels under aerobic growth conditions,
with or without the deletion of the ROX1 gene, show definitively
that these isoenzymes display similar turnover numbers and
affinities for oxygen and cyt c. Hence the origin of the
elevated activity of the 5B isoenzyme reported previously
[28,29] and confirmed in the present study with the equivalent
ROX1COX5A strain must be caused by a secondary effect.
Two possible explanations are discussed in the present paper.
Rox1 is a transcription repressor of many hypoxic genes
[49,50]. It is possible that its loss could cause increased 5B
isoenzyme activity through separate effects that might lead
to post-translational modification of subunit 5B, for example
phosphorylation or binding/unbinding of ATP/ADP [4,51].
However, elevated 5B isoenzyme activity has been previously
observed when expressed from a high copy number plasmid
both in the presence of ROX1 [30] and in a rox1-mutated strain
[28]. Furthermore, in the present study the 5B isoenzyme had
the same activity (and expression level) as the 5A isoenzyme
when expressed both with (in the COX5B strain) and without
(in the ROX1COX5ApCOX5B strain) a functioning Rox1
(Figure 1). All of the above argues against a secondary effect of
ROX1 deletion as the prime cause of the increased activity of the
5B isoenzyme when produced at low oxygen tensions or in strains
such as ROX1COX5A.
Elevated activity of the 5B isoenzyme has been observed
only when its expression level was significantly lower than in
wild-type strains, as is also the case for the ROX1COX5A
strain reported. Since the level of bc1 complex remains relatively
constant, this results in a proportionately lower CcO/bc1 ratio. It
has been shown that a proportion of CcO in yeast mitochondria can
be isolated as CcO–bc1 supercomplexes [52–54]; the proportion
of CcO in such supercomplexes will presumably be governed by
the CcO/bc1 ratio. It seems feasible that the interaction between
complexes may induce allosteric effects that elevate the catalytic
activity of CcO, an effect that becomes more evident when the
CcO/bc1 ratio is low since this will favour a greater proportion
of the CcO forming CcO–bc1 supercomplexes (simply from an
equilibrium constant point of view). Interestingly, the III2IV2
supercomplex structure of yeast CcO shows that subunit 5 is
close to the interface with the bc1 complex [54]. The extent of
c© 2014 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted
use, distribution and reproduction in any medium, provided the original work is properly cited.
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supercomplex formation, and the allosteric effect that it induces,
could be different with the 5A and 5B isoforms, providing a novel
possible functional basis for the existence of the isoenzymes.
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